Home > News & Events > Are you looking for COVID-19 Tests?

Are you looking for COVID-19 Tests?

01/02/2021 Event

DIAsource supplies multiple CE-IVD marked COVID-19 tests.

ELISA COVID-19  kits :

  • CE, IVD marked
  • detection of IgA, IgG and IgM antibodies against recombinant SARS-CoV-2 Nucleocapsid protein (NCP) or Receptor-binding domain (RBD)
  • NP – immunodominant, highly antigenic epitope; important in early diagnosis
  • RBD - S1 subunit of the spike protein, anti RBD antibodies are highly specific;IgA - indicator of the onset of the immune response
  • Easy protocol for programming on any OPEN ELISA platform
  • The kits are also available in SmartEIA format designed for automated processing and evaluation using the Agility® analyser

Rapid Screening Tests (RST) COVID-19 kits:

  • CE, IVD marked
  • Two versions :
    1. -RAPU08COVID19AG  for the qualitative detection of SARS-CoV-2 antigens present in human nasopharynx.
    2. -RAPU08COVID19 for qualitative detection of IgG and IgM antibodies to 2019-nCoV in human whole blood, serum or plasma specimens.
  • Results on the spot – 10 minutes
  • High sensitivity and specificity

NEW :also available now MICRO-ARRAY COVID-19 kits

  • CE, IVD marked
  • combination of selected parts of the specific antigens of SARS-CoV-2 (NCP, RBD, Spike S2, E, ACE2, PLPro protein)
  • and antigens for exclusion cross-reactivity with other endemic coronaviruses (MERS-CoV, SARS-CoV, HCoV 229E Np, HCoV NL63 Np).

For more information or to order : customer.service@diasource.be

To request a quote :eric.maes@diasource.be

back
Bridging Science And Diagnostics
Choose my country

DIAsource ImmunoAssays (formerly BioSource), experienced diagnostic manufacturer of RIA-ELISA-LIA immunoassays, validation on automates, large scale production of Antibodies-Point of Care Tests.

Please select your country to see the most accurate content available in your area.